Biological staging of head and neck cancer and its role in developing effective treatment strategies

American Joint Committee on Cancer. Manual for staging of cancer. J.B. Lippincott Co., Philadelphia, 1988, p 3 Wingo PA, Tong T, Bolden S: Cancer statistics, 1995. CA J Clin 45: 8–30, 1995 Schantz SP: Biologic staging of head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 1: 107–113, 1993 Tanabe KK: Cell adhesion in tumor invasion. Ann Surg Onc 2: 378–385, 1995 Terranorva VP, Hujanen ES, Martin GR: Basement membrane and the invasive activity of metastatic tumor cells. J Natl Cancer Inst 77: 311–316, 1986 Frixen UH, Behrens J, Sachs M, Eberle G, Vous B, Warda A, Lochner D, Birchmeier W: E-Cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173–185, 1991 Spiro RH, Huvos AG, Wong GY, Spiro JC, Gnecco CA, Strong EW: Predictive value of tumor thickness in squamous cell carcinoma confined to the tongue and floor of mouth. Am J Surg 152: 345–350, 1986 Begg CB, Zhang ZF, Sun M, Herr HW, Schantz SP: Methodology for evaluating incidence of second primary cancers with application to smoking-related cancers from S.E.E.R. Am J Epidemiol 142: 653–665, 1995 Malkin D, Li FP, Strong LC, Fraumeni JFJr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233–1238, 1990 Hsu TC: Genetic predisposition to cancer with special reference to mutagen sensitivity. In Vitro Cell Dev Biol 23: 591–603, 1987 Peltomaki P, Aaltonen LA, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Green JS, Jass JR, Weber JL, Leach FS, Petersen SM, Hamilton SR, de la Chapelle A, Vogelstein B: Genetic mapping of a locus predisposing to human colorectal cancer. Science (Washington) 60: 810–812, 1993 Spitz MR, Fueger JJ, Goepfert H, Hong WK, Newell GR: Squamous cell carcinoma of the upper aerodigestive tract: a case comparison analysis. Cancer 61: 203–208, 1988 Randerath E, Miller RH, Mittal D, Avitts TA, Dunsford HA, Randerath K: Covalent DNA damage in tissues of cigarette smokers as determined by the 32p-postlabelling assay. J Natl Cancer Inst 81: 341–347, 1989 Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855–4878, 1994 Hecht F: Fragile sites, cancer chromosome breakpoint and oncogenes all cluster in light G bands. Cancer Genet Cytogenet 31: 17–24, 1988 Randerath E, Randerath K: Monitoring tobacco smoke-induced DNA damage by 32p-postlabelling. In: Phillips DH, Castegnaro M, Bartsch H (eds) ‘Postlabelling Methods for Detection of DNA Adducts.’ Lyon: International Agency for Research on Cancer: 305–314, 1993 Hemminki K: DNA adducts, mutations, and cancer. Carcinogenesis 14: 2007–2012, 1993 Turtletaub KW, Frantz CE, Creek MR: DNA adducts in model systems and humans. J Cell Biochem (Suppl) 17F: 138–149, 1993 Randerath K, Putman KL, Osterberg HH, Johnson SA, Morgan DG, Finch CE: Age-dependent increases of DNA adducts (I-compounds) in human and rat brain DNA. Mutat Res 295: 11–18, 1993 Somers KD, Merrick MA, Lopez ME, Incognito LS, Schecter GL, Casey G: Frequent p53 mutations in head and neck cancer. Cancer Res 52: 5997–6000, 1992 Mazur M, Glickman BW: Sequence specificity of mutations induced by benzo(a)pyrene-7, 8-dial, 9, 10 epoxide at endogenous aprt gene in CHO cells. Somat Cell Mol Genet 114: 393–400, 1988 La Fuente A, Pujol F, Carretero P, Perez Villa J, Luchi A: Human glutathione-S-transferase mu deficiency: a Marker for susceptibility to bladder and larynx cancer. Cancer Lett 68: 49–54, 1993 Franco EL, Kowalski LP, Oliveira BV, Curado MP, Pereira RN, Silva ME, Fava AS, Torloni H: Risk factors for oral cancer in Brazil: a case-control study. Int J Cancer 43: 992–1000, 1989 Zheng T, Boyle P, Willett WC, Hu H, Dan J, Evstiffeeva TV, Niu S, MacMahon B: A case-control study of oral cancer in Beijing, People's Republic of China: associations with nutrient intakes, foods and food groups. Oral Oncol, Eur J Cancer 29B: 45–55, 1993 Rogers MAM, Thomas DB, Davis S, Weiss NS, Vaughan TL, Nevissi AE: A case-control study of oral cancer and prediagnostic concentrations of selenium and zinc in nail tissue. Int J Cancer 48: 182–188, 1991 Rossing MA, Vaughan TL, McNight B: Diet and pharyngeal cancer. Int J Cancer 44: 593–597, 1989 Ibrahim K, Jafarey NA, Zuberi SJ: Plasma vitamin A and carotene levels in squamous cell carcinoma of oral cavity and oropharynx. Clin Oncol 3: 203–207, 1977 Wolf GT: Tumor immunology, immune surveillance and immunotherapy of head and neck squamous carcinoma. In: Wolf GT (ed.) ‘Head and Neck Oncology.’ Boston: Martinus Nijhoff: 430–441, 1984 Parkinson DR, Schantz SP: The immunobiologic therapy of head and neck cancer. In: Snow G, Clark J (eds) ‘Multimodality Therapy for Head and Neck Cancer.’ Stuttgart: Georg Thieme Verlag: 147–159, 1992 Schantz SP, Lui FJ: An immunologic profile of young adults with head and neck cancer. Cancer 64: 1232–1237, 1989 Winn DM, Blot WJ, McLaughlin JK, Austin DF, Greenburg RS, Preston-Martin S, Schoenberg JB, Fraumeni JF: Mouthwash use and oral conditions in the risk of oral and pharyngeal cancer. Cancer Res 51: 3044–3047, 1991 Brachman DG, Graves D, Vokes E, Beckett M, Haraf D, Montag A, Dunphy E, Mick R, Yanell D, Weichselbaum RR: Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 52: 4832–4836, 1992 Coltrera MD, Zarbo RJ, Sakr WA, Gowen AM: Markers for dysplasia of the upper aerodigestive tract: suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue. Am J Path 141: 817–825, 1992 Glasgold R, Glasgold M, Savage H, Pinto J, Alfano R, Schantz S: Tissue autofluorescence as an intermediate endpoint in NMBA-induced esophageal carcinogenesis. Cancer Lett 82: 33–41, 1994 Grandis JR, Tweardy DJ: Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53: 3579–3584, 1993 DiMarco E, Albanese E, Benso S, Beatrice F, Cancedola R, Toma S: Expression of epidermal growth factor receptor and transforming growth factor alpha in human larynx carcinoma. Cancer Lett 65: 189–199, 1992 Hughes CJ, Reed JA, Cabal R, Huvos AG, Albino AP, Schantz SP: Inceased expression of basic fibroblast growth factor in squamous carcinogenesis of the head and neck is less prevalent following smoking cessation. Am J Surg 168: 381–385, 1994 Renan MJ: How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 7: 139–146 1993 Slaughter DP, Southwick HW, Smejkal W: ‘Field cancerization’ in oral stratified squamous epithelium. Cancer 6: 963–968, 1953 Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, Hong WK, Roth JA: Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 53: 1676–1683, 1993 Kanjilal S, Strom SS, Clayman GL, Weber RS, El-Naggar AK, Kapur V, Cummings KK, Hill LA, Spitz MR, Kripke ML, Ananthaswamy HN: p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res 55: 3604–3609, 1995 Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM, Rabbitts P: p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 7: 1989–1997, 1992 Van der Reit P, Nawroz H, Hruban RH, Corio R, Tokino K, Koch W, Sidransky D: Frequent loss of chromosome 9p21–22 early in head and neck cancer progression. Cancer Res 54: 1156–1158, 1994 El-Naggar AK, Hurr K, Batsakis JG, Luna MA, Goepfert H, Huff V: Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res 55: 2656–2659, 1995 Gritz ER, Carr CR, Rapkin DA, Abemayor E, Chang LJC, Wong WK, Berlin TR, Calcaterra T, Robbins KT, Chonkich G, Beumer J, Ward PH: Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 2: 261–270, 1993 Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, Dimery IW, Brown BW, Goepfert H: Prevention of second primary tumors with isotreinoin in squamous cell carcinoma of the head and neck. N Engl J Med 323: 795–801, 1990 Mayne ST, Goodwin WJ: Chemoprevention of head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 1: 126–132, 1993 Huang MT, Ho CT, Wang ZY, Ferraro T, Finnegan-Olive T, Lou YR, Mitchell JM, Laskin JD, Newmark H, Yang CS, Conney AH: Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis 13: 947–954, 1992 Yoshizawa S, Horiuchi T, Suganuma M, Nishiwaki S, Yatsunami J, Okabe S, Okuda T, Muto Y, Frenkel K, Troll W, Fugiki H: Penta-O-galloyl-β-D-glucose and (-)-epigallocatechin gallate: cancer prevention agent. In: Huang M-T, Ho C-T, Lee CY (eds) Phenolic Compounds in Foods and Health II: Antioxidants and Cancer Prevention. pp 316–325. Washington, DC: American Chemical Society, 1992 Yang CS, Hong J-Y, Wang Z-Y: Inhibition of nitrosamine-induced tumorigenesis by diallyl sulfide and tea. In: Waldron K (ed.) Food and Cancer Prevention '92, pp 247–252. Cambridge, United Kingdom: Royal Society of Chemistry, 1993 Wang Z-Y, Huang MT, Ferraro T, Wong CQ, Lou YR, Reuhl K, Iatropoulos M, Yang CS, Conney AH: Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice. Cancer Res 52: 6657–6665, 1992 Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH: Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54: 5841–5847, 1994 Huang MT, Deschner EE, Newmark HL, Wang ZY, Ferraro TA, Conney AH: Effect of dietary curcumin and ascorbyl palmitate on azoxymethanol-induced colonic epithelial cell proliferation and focal areas of dysplasia. Cancer Lett 64: 117–121, 1992 Nagabhushan M, Bhide SV: Curcumin as an inhibitor of cancer. J Am Coll Nutr 11: 192–198, 1992 Mukundan MA, Chacko MC, Annapurna VV, Krishnaswamy K: Effect of turmeric and curcumin on BP-DNA adducts. Carcinogenesis 14: 493–496, 1993 Marnett LJ: Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575–5589, 1992 Thun MJ, Namboodiri MM, Heath CWJr: Aspirin use and reduced rusk of fatal colon cancer. N Engl J Med 325: 1593–1596, 1991 Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Health CWJr: Aspirin use and risk of fatal cancer. Cancer Res 53: 1322–1327, 1993 Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M: Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma: a clinicopathologic study. Am J Clin Pathol 99: 18–23, 1993 Clayman G, Wang SW, Nicolson GL, El-Naggar A, Mazar A, Henkin J, Henkin J, Blasi F, Goepfert H, Boyd DD: Regulation of urokinase-type plasminogen activator expression in squamous cell carcinoma of the oral cavity. Int J Cancer 54: 73–80, 1993 Gray ST, Wilkins RJ, Yun K: Interstitial collagenase gene expression in oral squamous cell carcinoma. Am J Pathol 141: 301–306, 1992 Juarez J, Clayman G, Nakajima M, Tanabe KK, Saya H, Nicolson GL, Boyd D: Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous cell carcinoma cell lines of the oral cavity. Int J Cancer 55: 10–18, 1993 Lippman S, Hong WK: Editorial. Second malignant tumors in head and neck squamous cell carcinoma: The overshadowing threat for patients with early stage disease. Int J Radiation Oncology Biol Phys 17: 691–694, 1989 Boyle JO, Mao L, Brennan JA, Koch WM, Eisele DW, Saunders JR, Sidransky D: Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg 168: 429–432, 1994 Elo J: Relationship between ‘Dynamic Histology’ and metastases of laryngeal tumors. Acta Otolaryngol (Stockh) 112: 383–386, 1992 Tytor M, Olofsson J: Prognostic factors in oral cavity carcinomas. Acta Otolaryngol Suppl (Stockh) 492: 75–78, 1992 Schantz SP, Dimery I, Lippman S, Clayman GL, Pelligrino C, Morice R: A phase II study of interleukin-2 and interferon-alpha against head and neck cancer. Invest New Drugs 10: 217–223, 1992 Urba S, Forastiere AA, Amrein PS et al.: A phase-II pilot study of concomitantly administered recombinant human interleukin-2 (rlL-2) and roferon-A (rIFN) in patients with locally recurrent metastatic head and neck cancer. Proc Am Soc Clin Oncol 10: 208, 1991 Johnson JT, Myers EN, Mayernik DG, Nolan TA, Sigler BA, Wagner RL: Adjuvant methotrexate-5-fluorouracil for extracapsular squamous cell carcinoma in cervical metastasis. Laryngoscope 100: 590–592, 1990 Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL: Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res 54: 3662–3667, 1994 Clayman GL, El-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, Liu TJ: In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 55: 1–6, 1995 Loree TR, Strong EW: Significance of positive margins in oral cavity squamous carcinoma. Am J Surg 160: 410–414, 1990 Brennan JA, Mao L, Hruban RH, Boyle J, Eby YJ, Koch WM, Goodman SN, Sidransky D: Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332: 429–435, 1995 Harrison LB, Zelefsky MJ, Armstrong JG, Carper E, Gaynor JJ, Sessions RB: Performance status after treatment for squamous cell cancer of the base of tongue-a comparison of primary radiation therapy versus primary surgery. Int J Radiation Oncology Biol Phys 30: 953–957, 1994 List M, Ritter-Sterr C, Lansky S: A performance status scale for head and neck cancer patients. Cancer 66: 564–569, 1990 Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, Skingley P, Levine MN: Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328: 159–163, 1993 Field JK, Spandidos DA, Stell PM, Vaughan ED, Evan GI, Moore JP: Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene 4: 1463–1468, 1989 Somers KD, Schechter GL: Genetic alterations in head and neck cancer. Otolaryngol Clin North Am 25: 1065–1072, 1992 Hou L, Shi D, Tu SM, Zhang HZ, Hung MC, Ling D: Oral cancer progression and c-erb B-2/neu protooncogene. Cancer Lett 62: 215–220, 1992 Li X, Lee NK, Ye YW, Waber PG, Schweitzer C, Cheng QC, Nisen PD: Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer. J Natl Cancer Inst 86: 1524–1529, 1994 Lydiatt WM, Davidson BJ, Shah J, Schantz SP: The relationship of loss of heterozygosity to tobacco exposure and early recurrence in head and neck squamous cell carcinoma. Am J Surg 168: 437–440, 1994 Lydiatt DD, Savage HE, Clayman GL, Liu FJ, Sample D, Schantz SP: Serologic determinants of survival in patients with head and neck cancer: validating a clinical prediction model. Laryngoscope 103: 13–16, 1993 Patel BK, Kasid U: Nucleotide analysis of c-raf-1 cDNA and promoter from a radiation-resistant human squamous carcinoma cell line: deletion within exon 17. Mol Carcinog 8: 7–12, 1993 Kasid U, Pirollo K, Dritschillo A, Chang E: Oncogenic basis of radiation resistance. Adv Cancer Res 61: 195–233, 1993 Lara PC, Cuyas JM: The role of squamous cell carcinoma antigen in the management of laryngeal and hypopharyngeal cancer. Cancer 76: 758–764, 1995 Maruo T, Shibata K, Kimura A, Hoshina M, Mochizuki M: Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix: serial determinations and tissue localization. Cancer 56: 302–308, 1985 Rassekh CH, Johnson JT, Eibling DE: Circulating markers in squamous cell carcinoma of the head and neck: a review. Oral Oncol, Eur J Cancer 30B: 23–28, 1994